Combination therapy for Type 2 diabetes: repaglinide plus rosiglitazone.
Raskin, P.; McGill, J.; Saad, M.F.; Cappleman, J.M.; Kaye, W.; Khutoryansky, N.; Hale, P.M.; Diabetic Medicine, 2004, vol. 21, issue 4, p 329, ISSN 07423071. ISBN 07423071.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef